Day GA - Search Results

1

Characterization of physicochemical properties of beryllium aerosols associated with prevalence of chronic beryllium disease.

Stefaniak AB, Hoover MD, Day GA, Dickerson RM, Peterson EJ, Kent MS, Schuler CR, Breysse PN, Scripsick RC. Stefaniak AB, et al. Among authors: day ga. J Environ Monit. 2004 Jun;6(6):523-32. doi: 10.1039/b316256g. Epub 2004 Mar 22. J Environ Monit. 2004. PMID: 15173904 Review.

2

Characterization of phagolysosomal simulant fluid for study of beryllium aerosol particle dissolution.

Stefaniak AB, Guilmette RA, Day GA, Hoover MD, Breysse PN, Scripsick RC. Stefaniak AB, et al. Among authors: day ga. Toxicol In Vitro. 2005 Feb;19(1):123-34. doi: 10.1016/j.tiv.2004.08.001. Toxicol In Vitro. 2005. PMID: 15582363

3

Surface area of respirable beryllium metal, oxide, and copper alloy aerosols and implications for assessment of exposure risk of chronic beryllium disease.

Stefaniak AB, Hoover MD, Dickerson RM, Peterson EJ, Day GA, Breysse PN, Kent MS, Scripsick RC. Stefaniak AB, et al. Among authors: day ga. AIHA J (Fairfax, Va). 2003 May-Jun;64(3):297-305. doi: 10.1080/15428110308984820. AIHA J (Fairfax, Va). 2003. PMID: 12809534

4

Differences in dissolution behavior in a phagolysosomal simulant fluid for single-constituent and multi-constituent materials associated with beryllium sensitization and chronic beryllium disease.

Stefaniak AB, Day GA, Hoover MD, Breysse PN, Scripsick RC. Stefaniak AB, et al. Among authors: day ga. Toxicol In Vitro. 2006 Feb;20(1):82-95. doi: 10.1016/j.tiv.2005.06.031. Epub 2005 Aug 2. Toxicol In Vitro. 2006. PMID: 16061346

5

Physicochemical characteristics of aerosol particles generated during the milling of beryllium silicate ores: implications for risk assessment.

Stefaniak AB, Chipera SJ, Day GA, Sabey P, Dickerson RM, Sbarra DC, Duling MG, Lawrence RB, Stanton ML, Scripsick RC. Stefaniak AB, et al. Among authors: day ga. J Toxicol Environ Health A. 2008;71(22):1468-81. doi: 10.1080/15287390802349883. J Toxicol Environ Health A. 2008. PMID: 18836922

6

Dissolution of cemented carbide powders in artificial sweat: implications for cobalt sensitization and contact dermatitis.

Stefaniak AB, Harvey CJ, Virji MA, Day GA. Stefaniak AB, et al. Among authors: day ga. J Environ Monit. 2010 Oct 6;12(10):1815-22. doi: 10.1039/c0em00269k. Epub 2010 Aug 23. J Environ Monit. 2010. PMID: 20730217

7

Bioavailability of beryllium oxide particles: an in vitro study in the murine J774A.1 macrophage cell line model.

Day GA, Hoover MD, Stefaniak AB, Dickerson RM, Peterson EJ, Esmen NA, Scripsick RC. Day GA, et al. Exp Lung Res. 2005 Apr;31(3):341-60. doi: 10.1080/01902140590918731. Exp Lung Res. 2005. PMID: 15962713

8

Beryllium exposure: dermal and immunological considerations.

Day GA, Stefaniak AB, Weston A, Tinkle SS. Day GA, et al. Int Arch Occup Environ Health. 2006 Feb;79(2):161-4. doi: 10.1007/s00420-005-0024-0. Epub 2005 Oct 18. Int Arch Occup Environ Health. 2006. PMID: 16231190 Review.

9

Exposure pathway assessment at a copper-beryllium alloy facility.

Day GA, Dufresne A, Stefaniak AB, Schuler CR, Stanton ML, Miller WE, Kent MS, Deubner DC, Kreiss K, Hoover MD. Day GA, et al. Ann Occup Hyg. 2007 Jan;51(1):67-80. doi: 10.1093/annhyg/mel041. Epub 2006 Jul 14. Ann Occup Hyg. 2007. PMID: 16844720

10

Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.

Cummings KJ, Deubner DC, Day GA, Henneberger PK, Kitt MM, Kent MS, Kreiss K, Schuler CR. Cummings KJ, et al. Among authors: day ga. Occup Environ Med. 2007 Feb;64(2):134-40. doi: 10.1136/oem.2006.027987. Epub 2006 Oct 16. Occup Environ Med. 2007. PMID: 17043076 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page